Table 1 Characteristics of Wave 1 participants with valid data on COPDa status (N = 13,752)
Sociodemographics, Tobacco Use, and Medical History | Adults age 40 and above (N = 13,752) | Adults with self-reported doctor or other health professional diagnosis of COPDa (N = 1506) | Adults without self-reported doctor or other health professional diagnosis of COPDa (N = 12,246) | ||||||
|---|---|---|---|---|---|---|---|---|---|
Nb | Weighted %/Mean | SE | Nb | Weighted %/Mean | SE | Nb | Weighted %/Mean | SE | |
Sociodemographics | |||||||||
Age in years, mean | 13,752 | 58.1 | 0.1 | 1506 | 63.1 | 0.5 | 12,246 | 57.7 | 0.1 |
Sex, N (%) male | 6943 | 47.2% | 0.2 | 627 | 41.2% | 1.7 | 6316 | 47.7% | 0.3 |
Race, N (%) non-Hispanic white | 9306 | 71.4% | 0.3 | 1128 | 79.6% | 1.2 | 8178 | 70.7% | 0.4 |
Hispanic ethnicity, N (%) | 1629 | 11.4% | 0.3 | 98 | 6.9% | 0.8 | 1531 | 11.8% | 0.3 |
Less than high school education, N (%) | 2963 | 17.4% | 0.1 | 492 | 31.1% | 1.8 | 2471 | 16.3% | 0.2 |
Live in urban area, N (%) | 10,157 | 75.5% | 1.8 | 1029 | 69.3% | 2.8 | 9128 | 76.0% | 1.7 |
Tobacco use | |||||||||
Ever (100+) cigarette smoker, N (%) | 7952 | 41.1% | 0.7 | 1207 | 70.2% | 1.7 | 6745 | 38.7% | 0.7 |
Pack-yearsc, mean | 10,861 | 14.2 | 0.3 | 1394 | 29.4 | 0.8 | 9467 | 12.6 | 0.3 |
Any past 30 day tobacco use categories | |||||||||
P30D cigarette use, N (%) | 5983 | 18.3% | 0.3 | 1043 | 40.5% | 1.4 | 4940 | 16.5% | 0.3 |
P30D cigar use, N (%) | 1265 | 4.4% | 0.1 | 168 | 7.1% | 0.6 | 1097 | 4.2% | 0.1 |
P30D traditional cigar use, N (%) | 756 | 2.6% | 0.1 | 78 | 3.0% | 0.3 | 678 | 2.5% | 0.1 |
P30D cigarillo use, N (%) | 586 | 2.0% | 0.1 | 74 | 3.1% | 0.4 | 512 | 1.9% | 0.1 |
P30 filtered cigar use, N (%) | 403 | 1.3% | 0.1 | 94 | 3.9% | 0.5 | 309 | 1.1% | 0.1 |
P30D hookah use, N (%) | 95 | 0.3% | 0.0 | 14 | 0.5% | 0.1 | 81 | 0.3% | 0.0 |
P30D e-cigarette use, N (%) | 1393 | 4.1% | 0.1 | 265 | 9.8% | 0.7 | 1128 | 3.7% | 0.1 |
P30D smokeless/snus use, N (%) | 746 | 2.4% | 0.1 | 49 | 2.1% | 0.4 | 697 | 2.5% | 0.1 |
Mutually exclusive P30D tobacco use categoriesd | |||||||||
Never use (Never or former experimental tobacco) | 3817 | 51.7% | 0.7 | 120 | 21.4% | 1.9 | 3697 | 54.2% | 0.7 |
Former tobacco use | 2173 | 25.2% | 0.6 | 225 | 33.5% | 1.9 | 1948 | 24.5% | 0.6 |
Exclusive cigarette use | 3773 | 12.5% | 0.3 | 634 | 27.4% | 1.3 | 3139 | 11.3% | 0.3 |
Exclusive e-cigarette use | 198 | 0.6% | 0.0 | 26 | 1.0% | 0.2 | 172 | 0.6% | 0.0 |
Exclusive cigar use | 391 | 1.6% | 0.1 | 18 | 1.0% | 0.2 | 373 | 1.7% | 0.1 |
Exclusive smokeless/snus use | 482 | 1.7% | 0.1 | 27 | 1.3% | 0.4 | 455 | 1.8% | 0.1 |
Exclusive P30D cigarette and e-cigarette use | 852 | 2.7% | 0.1 | 166 | 6.7% | 0.6 | 686 | 2.4% | 0.1 |
Polycombusted tobacco use | 619 | 2.0% | 0.1 | 113 | 4.6% | 0.5 | 506 | 1.8% | 0.1 |
Polycombusted and noncombusted use | 461 | 1.5% | 0.1 | 70 | 3.0% | 0.3 | 391 | 1.3% | 0.1 |
Medical history (self-reported) | |||||||||
Total COPDa diagnosis, N (%) | 1506 | 7.7% | 0.3 | 1506 | 100.0% | N/A | N/A | N/A | N/A |
COPDe diagnosis, N (%) | 939 | 4.6% | 0.2 | 939 | 60.1% | 1.8 | N/A | N/A | N/A |
Chronic bronchitis diagnosis, N (%) | 762 | 3.9% | 0.2 | 762 | 50.6% | 1.8 | N/A | N/A | N/A |
Emphysema diagnosis, N (%) | 456 | 2.0% | 0.1 | 456 | 26.5% | 1.4 | N/A | N/A | N/A |
BMI, kg/m2, mean | 13,465 | 28.4 | 0.1 | 1477 | 29.7 | 0.3 | 11,988 | 28.3 | 0.1 |
Comorbidity index,f mean | 13,383 | 1.5 | 0.0 | 1466 | 2.6 | 0.1 | 11,917 | 1.4 | 0.0 |